paroxetine has been researched along with gbr 12935 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caldecott-Hazard, S; Weissman, AD | 1 |
Besnard, JC; Boazi, M; Bricard, J; Caillet, M; Chalon, S; Emond, P; Frangin, Y; Garreau, L; Guilloteau, D; Mauclaire, L | 1 |
Bock, N; Huether, G; Mehnert, C; Moll, GH; Rothenberger, A; Rüther, E; Wicker, M | 1 |
Hause, S; Huether, G; Moll, GH; Rothenberger, A; Rüther, E | 1 |
Rehavi, M; Roz, N; Weizman, A | 1 |
Lesch, KP; Murphy, DL; Zhou, FC | 1 |
6 other study(ies) available for paroxetine and gbr 12935
Article | Year |
---|---|
In utero methamphetamine effects: I. Behavior and monoamine uptake sites in adult offspring.
Topics: Animals; Behavior, Animal; Biogenic Monoamines; Brain; Female; Male; Mazindol; Methamphetamine; Paroxetine; Piperazines; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley | 1993 |
Synthesis and ligand binding of nortropane derivatives: N-substituted 2beta-carbomethoxy-3beta-(4'-iodophenyl)nortropane and N-(3-iodoprop-(2E)-enyl)-2beta-carbomethoxy-3beta-(3',4'-disubstituted phenyl)nortropane. New high-affinity and selective compound
Topics: Animals; Brain; Carrier Proteins; Dopamine Plasma Membrane Transport Proteins; Fluoxetine; Ligands; Magnetic Resonance Spectroscopy; Mass Spectrometry; Membrane Glycoproteins; Membrane Transport Proteins; Molecular Structure; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; Nortropanes; Paroxetine; Piperazines; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Symporters | 1997 |
Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood.
Topics: Aging; Animals; Brain; Brain Stem; Carrier Proteins; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Female; Fluoxetine; Frontal Lobe; Ligands; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; Paroxetine; Piperazines; Presynaptic Terminals; Protein Binding; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Symporters; Tritium | 2000 |
Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters.
Topics: Animals; Brain Chemistry; Carrier Proteins; Central Nervous System Stimulants; Dopamine Plasma Membrane Transport Proteins; Fluoxetine; Kinetics; Ligands; Membrane Glycoproteins; Membrane Transport Proteins; Membranes; Mesencephalon; Methylphenidate; Neostriatum; Nerve Tissue Proteins; Paroxetine; Piperazines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors | 2001 |
Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2.
Topics: Animals; Antipsychotic Agents; Binding Sites; Biological Transport; Brain; Brain Chemistry; Clozapine; Drug Administration Schedule; Fluoxetine; Haloperidol; In Situ Hybridization; Male; Membrane Glycoproteins; Membrane Transport Proteins; Neuropeptides; Paroxetine; Piperazines; Rats; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2002 |
Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative.
Topics: Animals; Animals, Newborn; Carrier Proteins; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Immunohistochemistry; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Knockout; Nerve Tissue Proteins; Neurons; Paroxetine; Piperazines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Substantia Nigra; Synaptic Transmission; Ventral Tegmental Area | 2002 |